149 related articles for article (PubMed ID: 16928829)
21. Androgen receptor induces EPHA3 expression by interacting with transcription factor SP1.
Diao X; Chen X; Pi Y; Zhang Y; Wang F; Liu P; Gao Y; Wang X; Yang S; Lu S
Oncol Rep; 2018 Aug; 40(2):1174-1184. PubMed ID: 29917167
[TBL] [Abstract][Full Text] [Related]
22. Tea polyphenols down-regulate the expression of the androgen receptor in LNCaP prostate cancer cells.
Ren F; Zhang S; Mitchell SH; Butler R; Young CY
Oncogene; 2000 Apr; 19(15):1924-32. PubMed ID: 10773882
[TBL] [Abstract][Full Text] [Related]
23. Tumor-selective killing by selenite in patient-matched pairs of normal and malignant prostate cells.
Husbeck B; Nonn L; Peehl DM; Knox SJ
Prostate; 2006 Feb; 66(2):218-25. PubMed ID: 16173037
[TBL] [Abstract][Full Text] [Related]
24. SOD mimetics: a novel class of androgen receptor inhibitors that suppresses castration-resistant growth of prostate cancer.
Thomas R; Sharifi N
Mol Cancer Ther; 2012 Jan; 11(1):87-97. PubMed ID: 22172488
[TBL] [Abstract][Full Text] [Related]
25. Expression of p53 enhances selenite-induced superoxide production and apoptosis in human prostate cancer cells.
Zhao R; Xiang N; Domann FE; Zhong W
Cancer Res; 2006 Feb; 66(4):2296-304. PubMed ID: 16489034
[TBL] [Abstract][Full Text] [Related]
26. Methylseleninic acid potentiates apoptosis induced by chemotherapeutic drugs in androgen-independent prostate cancer cells.
Hu H; Jiang C; Ip C; Rustum YM; Lü J
Clin Cancer Res; 2005 Mar; 11(6):2379-88. PubMed ID: 15788689
[TBL] [Abstract][Full Text] [Related]
27. Androgenic up-regulation of androgen receptor cDNA expression in androgen-independent prostate cancer cells.
Dai JL; Maiorino CA; Gkonos PJ; Burnstein KL
Steroids; 1996 Sep; 61(9):531-9. PubMed ID: 8883219
[TBL] [Abstract][Full Text] [Related]
28. The androgen receptor negatively regulates the expression of c-Met: implications for a novel mechanism of prostate cancer progression.
Verras M; Lee J; Xue H; Li TH; Wang Y; Sun Z
Cancer Res; 2007 Feb; 67(3):967-75. PubMed ID: 17283128
[TBL] [Abstract][Full Text] [Related]
29. Caspases as key executors of methyl selenium-induced apoptosis (anoikis) of DU-145 prostate cancer cells.
Jiang C; Wang Z; Ganther H; Lu J
Cancer Res; 2001 Apr; 61(7):3062-70. PubMed ID: 11306488
[TBL] [Abstract][Full Text] [Related]
30. Androgen receptor activation in prostatic tumor cell lines by insulin-like growth factor-I, keratinocyte growth factor, and epidermal growth factor.
Culig Z; Hobisch A; Cronauer MV; Radmayr C; Trapman J; Hittmair A; Bartsch G; Klocker H
Cancer Res; 1994 Oct; 54(20):5474-8. PubMed ID: 7522959
[TBL] [Abstract][Full Text] [Related]
31. Combination of carmustine and selenite effectively inhibits tumor growth by targeting androgen receptor, androgen receptor-variants, and Akt in preclinical models: New hope for patients with castration resistant prostate cancer.
Thamilselvan V; Menon M; Thamilselvan S
Int J Cancer; 2016 Oct; 139(7):1632-47. PubMed ID: 27198552
[TBL] [Abstract][Full Text] [Related]
32. Redox modulation of human prostate carcinoma cells by selenite increases radiation-induced cell killing.
Husbeck B; Peehl DM; Knox SJ
Free Radic Biol Med; 2005 Jan; 38(1):50-7. PubMed ID: 15589371
[TBL] [Abstract][Full Text] [Related]
33. Indole-3-carbinol inhibition of androgen receptor expression and downregulation of androgen responsiveness in human prostate cancer cells.
Hsu JC; Zhang J; Dev A; Wing A; Bjeldanes LF; Firestone GL
Carcinogenesis; 2005 Nov; 26(11):1896-904. PubMed ID: 15958518
[TBL] [Abstract][Full Text] [Related]
34. Transcriptional regulation of the androgen signaling pathway by the Wilms' tumor suppressor gene WT1.
Zaia A; Fraizer GC; Piantanelli L; Saunders GF
Anticancer Res; 2001; 21(1A):1-10. PubMed ID: 11299720
[TBL] [Abstract][Full Text] [Related]
35. 1,4-phenylenebis(methylene)selenocyanate, but not selenomethionine, inhibits androgen receptor and Akt signaling in human prostate cancer cells.
Facompre ND; El-Bayoumy K; Sun YW; Pinto JT; Sinha R
Cancer Prev Res (Phila); 2010 Aug; 3(8):975-84. PubMed ID: 20606040
[TBL] [Abstract][Full Text] [Related]
36. Phenylbutyl isoselenocyanate induces reactive oxygen species to inhibit androgen receptor and to initiate p53-mediated apoptosis in LNCaP prostate cancer cells.
Wu W; Karelia D; Pramanik K; Amin SG; Sharma AK; Jiang C; Lu J
Mol Carcinog; 2018 Aug; 57(8):1055-1066. PubMed ID: 29668110
[TBL] [Abstract][Full Text] [Related]
37. Diverse effects of methylseleninic acid on the transcriptional program of human prostate cancer cells.
Zhao H; Whitfield ML; Xu T; Botstein D; Brooks JD
Mol Biol Cell; 2004 Feb; 15(2):506-19. PubMed ID: 14617803
[TBL] [Abstract][Full Text] [Related]
38. Antiandrogenic effects of novel androgen synthesis inhibitors on hormone-dependent prostate cancer.
Long BJ; Grigoryev DN; Nnane IP; Liu Y; Ling YZ; Brodie AM
Cancer Res; 2000 Dec; 60(23):6630-40. PubMed ID: 11118046
[TBL] [Abstract][Full Text] [Related]
39. Selenite treatment inhibits LAPC-4 tumor growth and prostate-specific antigen secretion in a xenograft model of human prostate cancer.
Bhattacharyya RS; Husbeck B; Feldman D; Knox SJ
Int J Radiat Oncol Biol Phys; 2008 Nov; 72(3):935-40. PubMed ID: 18760546
[TBL] [Abstract][Full Text] [Related]
40. Methylseleninic Acid Superactivates p53-Senescence Cancer Progression Barrier in Prostate Lesions of Pten-Knockout Mouse.
Wang L; Guo X; Wang J; Jiang C; Bosland MC; Lü J; Deng Y
Cancer Prev Res (Phila); 2016 Jan; 9(1):35-42. PubMed ID: 26511486
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
